Annual Retained Earnings
-$1.61 B
-$51.92 M-3.33%
31 December 2023
Summary:
Akebia Therapeutics annual retained earnings is currently -$1.61 billion, with the most recent change of -$51.92 million (-3.33%) on 31 December 2023. During the last 3 years, it has fallen by -$431.44 million (-36.64%). AKBA annual retained earnings is now -2600.12% below its all-time high of -$59.59 million, reached on 31 December 2012.AKBA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.66 B
-$20.04 M-1.23%
30 September 2024
Summary:
Akebia Therapeutics quarterly retained earnings is currently -$1.66 billion, with the most recent change of -$20.04 million (-1.23%) on 30 September 2024. Over the past year, it has dropped by -$45.99 million (-2.86%). AKBA quarterly retained earnings is now -2157.49% below its all-time high of -$73.34 million, reached on 31 March 2014.AKBA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | -2.9% |
| 3 y3 years | -36.6% | -19.1% |
| 5 y5 years | -212.8% | -136.7% |
AKBA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.6% | at low | -19.1% | at low |
| 5 y | 5 years | -212.8% | at low | -136.7% | at low |
| alltime | all time | -2600.1% | at low | -2157.5% | at low |
Akebia Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.66 B(+1.2%) |
| June 2024 | - | -$1.64 B(+0.5%) |
| Mar 2024 | - | -$1.63 B(+1.1%) |
| Dec 2023 | -$1.61 B(+3.3%) | -$1.61 B(-0.0%) |
| Sept 2023 | - | -$1.61 B(+0.9%) |
| June 2023 | - | -$1.60 B(+1.0%) |
| Mar 2023 | - | -$1.58 B(+1.4%) |
| Dec 2022 | -$1.56 B(+6.4%) | -$1.56 B(+0.8%) |
| Sept 2022 | - | -$1.55 B(+3.5%) |
| June 2022 | - | -$1.49 B(-1.9%) |
| Mar 2022 | - | -$1.52 B(+4.1%) |
| Dec 2021 | -$1.46 B(+24.2%) | -$1.46 B(+5.3%) |
| Sept 2021 | - | -$1.39 B(+4.5%) |
| June 2021 | - | -$1.33 B(+6.7%) |
| Mar 2021 | - | -$1.25 B(+5.9%) |
| Dec 2020 | -$1.18 B(+48.3%) | -$1.18 B(+8.0%) |
| Sept 2020 | - | -$1.09 B(+5.8%) |
| June 2020 | - | -$1.03 B(+20.6%) |
| Mar 2020 | - | -$854.80 M(+7.7%) |
| Dec 2019 | -$794.05 M | -$794.05 M(+13.5%) |
| Sept 2019 | - | -$699.57 M(+8.5%) |
| June 2019 | - | -$644.99 M(+9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$586.82 M(+14.1%) |
| Dec 2018 | -$514.39 M(+38.7%) | -$514.39 M(+13.2%) |
| Sept 2018 | - | -$454.34 M(+6.1%) |
| June 2018 | - | -$428.29 M(+8.6%) |
| Mar 2018 | - | -$394.23 M(+6.3%) |
| Dec 2017 | -$370.81 M(+24.8%) | -$370.81 M(-4.0%) |
| Sept 2017 | - | -$386.33 M(+6.4%) |
| June 2017 | - | -$363.20 M(+6.3%) |
| Mar 2017 | - | -$341.68 M(+15.0%) |
| Dec 2016 | -$297.14 M(+84.1%) | -$297.14 M(+14.6%) |
| Sept 2016 | - | -$259.27 M(+16.3%) |
| June 2016 | - | -$222.97 M(+19.1%) |
| Mar 2016 | - | -$187.19 M(+16.0%) |
| Dec 2015 | -$161.39 M(+60.3%) | -$161.39 M(+14.0%) |
| Sept 2015 | - | -$141.53 M(+16.0%) |
| June 2015 | - | -$122.06 M(+9.6%) |
| Mar 2015 | - | -$111.37 M(+10.6%) |
| Dec 2014 | -$100.67 M(-20.8%) | -$100.67 M(+11.5%) |
| Sept 2014 | - | -$90.30 M(+11.5%) |
| June 2014 | - | -$80.95 M(+10.4%) |
| Mar 2014 | - | -$73.34 M(-42.3%) |
| Dec 2013 | -$127.07 M(+113.3%) | -$127.07 M |
| Dec 2012 | -$59.59 M | - |
FAQ
- What is Akebia Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Akebia Therapeutics?
- What is Akebia Therapeutics annual retained earnings year-on-year change?
- What is Akebia Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly retained earnings year-on-year change?
What is Akebia Therapeutics annual retained earnings?
The current annual retained earnings of AKBA is -$1.61 B
What is the all time high annual retained earnings for Akebia Therapeutics?
Akebia Therapeutics all-time high annual retained earnings is -$59.59 M
What is Akebia Therapeutics annual retained earnings year-on-year change?
Over the past year, AKBA annual retained earnings has changed by -$51.92 M (-3.33%)
What is Akebia Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AKBA is -$1.66 B
What is the all time high quarterly retained earnings for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly retained earnings is -$73.34 M
What is Akebia Therapeutics quarterly retained earnings year-on-year change?
Over the past year, AKBA quarterly retained earnings has changed by -$45.99 M (-2.86%)